Compounded Aseptic Medicines

GreatbritainTenders notice for Compounded Aseptic Medicines. The reference ID of the tender is 117475185 and it is closing on 24 May 2025.

100% Secure Payments

Tender Details

  • Country: United Kingdom
  • Summary: Compounded Aseptic Medicines
  • GBT Ref No: 117475185
  • Deadline: 24 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: NP38626
  • Purchaser's Detail :
  • Purchaser : THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
    The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) 1 South Gyle Crescent Edinburgh EH12 9EB
    Country : United Kingdom
    Telephone : +44 1312756000
    Email :stephanie.hammel@nhs.scot

  • Description :
  • This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags
    Notice identifier : 2025/S 000-014034
    CPV classifications: 33600000 - Pharmaceutical products
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
GreatbritainTenders Features

GreatbritainTenders Features

Fresh and verified Tenders from Greatbritain. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Greatbritain in your email inbox.

  Chat with us